TCL Archive Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival September 28, 2012
TCL Archive High Response Rate of Hairy Cell Leukemia Patients to Immunotoxin Treatment In Phase I April 27, 2001